Hailong Chen
Ganzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integrative single-cell sequencing and machine learning analyses identify chronic inflammation and cancer-associated fibroblast subsets as drivers of adverse outcomes in ovarian cancer.
Journal: Translational oncology
Published: March 27, 2026
UBD-mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion.
Journal: Journal of cell communication and signaling
Published: January 29, 2025
Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study.
Journal: Frontiers in oncology
Published: March 12, 2024
Effect of 3D laparoscopy versus traditional laparotomy on serum tumor markers and coagulation function in patients with early-stage endometrial cancer.
Journal: Clinics (Sao Paulo, Brazil)
Published: December 01, 2023
A postoperative tumor-specific death prediction model for patients with endometrial cancer: a retrospective study.
Journal: Translational cancer research
Published: October 22, 2023
Clinical analysis of decision implementation by a multidisciplinary team in cervical cancer cases in Ganzhou, China.
Journal: Frontiers in oncology
Published: February 07, 2023
YBX1, Targeted By Microrna-382-5p, Promotes Laryngeal Squamous Cell Carcinoma Progression via Modulating RAS/MAPK Signaling.
Journal: Recent patents on anti-cancer drug discovery
Published: October 16, 2022
Orai1-mediated store-operated Ca2+ entry promotes cervical cancer progression through IL-6 signaling.
Journal: Frontiers in molecular biosciences
Published: September 11, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026